UK investments help drive growth for pharmaceuticals giant
Pharmaceutical company STADA, which is owned by UK private equity funds Cinven and Bain Capital, has reported revenues of €3bn/£2.6bn.
STADA has a major presence in the UK pharmaceutical and healthcare market with Thornton & Ross – founded in Huddersfield in 1922 – a manufacturer of brands such as Covonia, Savlon, Hedrin and Zoflora.
The Group also includes Natures Aid, a natural supplements business, and Britannia, an affiliate bringing innovative treatments for Parkinson’s disease.
Despite the pandemic and Brexit, the business has still been able to invest in its UK operations.
A multi-million pound investment in its site at Linthwaite near Huddersfield has transformed it into a centre of excellence for liquids, such as Covonia, household products like Zoflora and semi-solids such as emollient creams and ointments.
The UK arm of the business is also leading an expansion into the US market. And UK brands such as Zoflora and Hedrin are increasingly becoming international export brands to locations such as Australia, Hong Kong, Serbia and the UAE.
CEO Peter Goldschmidt said: “While we have responded with agility to the pandemic, we have continued to strengthen our supply-chain infrastructure for a sustainable future.
“I am proud of how STADA has worked tirelessly with hundreds of partners amid the pandemic to keep supplying medicines and deliver on our purpose of caring for people’s health as a trusted partner.
“Our above-market sales and profit increases reflect the extraordinary engagement and entrepreneurship of our diverse global workforce.
“Our strategy to position STADA as the go-to-partner for consumer healthcare, specialty pharmaceuticals and generics is succeeding.”
Roger Scarlett-Smith, executive vice president, STADA UK and North America said: “Our above-market global performance has been mirrored in the UK, indicative of the resilience of our people in the face of turbulent market conditions.
“A major multi-million pound investment in STADA’s Huddersfield facility is transforming the site into a STADA centre of excellence for liquids and semi-solids.
“The UK business is also spearheading STADA’s growing presence in the US consumer healthcare arena, as well as delivering major export successes including Zoflora and Hedrin.”
